Scirease

  • About Us
  • SciTrends
  • SciJobs
  • Contact Us
  • Infectious Diseases, Salmonella

    Development of a closed-tube, calcein-based loop-mediated isothermal amplification assay to detect Salmonella spp. in raw meat samples

    March 23, 2024

    Salmonella spp. are among the main pathogenic bacteria that cause outbreaks globally. Foodborne infections jeopardize…

  • Infectious Diseases, Salmonella

    A bacteriophage cocktail can efficiently reduce five important Salmonella serotypes both on chicken skin and stainless steel

    March 23, 2024

    One of the most significant zoonotic infections, salmonella is primarily spread by eating food that…

  • Infectious Diseases, Salmonella

    Antimicrobial drug resistance in Salmonella: problems and perspectives in food- and water-borne infections

    March 17, 2024

    Antimicrobial drug-resistant strains of Salmonella spp. are becoming common in both industrialized and developing nations.…

  • Cancer, Drug Discovery

    Targeting hypoxia-inducible factors: therapeutic opportunities and challenges

    January 20, 2024

    Hypoxia-inducible factors (HIFs) are highly conserved transcription factors that are crucial for adaptation of metazoans…

  • Cancer

    Early Cancer Detection in Li–Fraumeni Syndrome with Cell-Free DNA

    January 15, 2024

    As you may have heard that Liquid biopsy has become an attractive tool for a…

  • Cancer, Cancer Cell, Drug Discovery

    AMG 509 (Xaluritamig), an Anti-STEAP1 XmAb 2+1 T-cell Redirecting Immune Therapy with Avidity-Dependent Activity against Prostate Cancer 

    January 15, 2024

    Researchers promises that AMG 509 provides a targeted immunotherapy approach to engage a patient’s T…

  • Cancer, Drug Discovery

    First-in-Human Study of the Reversible BTK Inhibitor Nemtabrutinib in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia and B-Cell Non–Hodgkin Lymphoma 

    January 15, 2024

    A recent first-in-human phase I study shows the safety and preliminary efficacy of nemtabrutinib in…

  • Drug Discovery

    A new type of antibiotic targets a drug-resistant bacterium

    January 15, 2024

    It’s always been hard to treat the Infections caused by drug-resistant strains of the bacterium…

  • Cancer

    A global phase 3 study of serplulimab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (ASTRUM-004)

    January 7, 2024

    A recent study shows that First-line serplulimab plus chemotherapy improves PFS and OS and promises…

  • Biology, Cancer, Cancer Cell, Immunotherapy

    Interferon-stimulated neutrophils as a predictor of immunotherapy response

    January 7, 2024

    Researchers indentified interferon-stimulated, Ly6Ehi neutrophils as a blood-borne biomarker of anti-PD1 response in mice at…

←Previous Page
1 2 3
Next Page→
Scirease

We are dedicated to advancing scientific communication and fostering collaboration among researchers, scholars, and industry experts.

SCIREASE Pvt Ltd.
#106, Aditya Sunshine, Kondapur, Hyderabad, Telangana, India, 500084.
Phone: +91 701-351-8698
Email: contact@scirease.org

  • LinkedIn
  • X

Products

  • Conferences
  • SciTrends
  • SciJobs

Company

  • About Us
  • Contact Us
  • Careers
  • Privacy Policy

© 2025 SCIREASE is a registered company under India’s MCA Act with Corporate Identification Number (CIN) U85491TS2023PTC178967 | ®All Rights Reserved